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TECHNICAL NOTE
Norepinephrine-induced acute renal failure: A reversible
ischemic model of acute renal failure
ROBERT E. CRONIN, ABBY M. ERICKSON, ANTOINE DE TORRENTE, KEITH M. MCDONALD,
and ROBERT W. SCHRIER
Department of Medicine, University of Colorado School ofMedicine, Denver, Colorado
Several studies have shown that acute renal failure
(ARF) can be produced in the dog by infusing norepi-
nephrine (NE) into a renal artery [1, 2]. Tn these
studies the injury appeared to be confined to the
infused kidney, with no changes occurring in sys-
temic hemodynamics or in the function of the contra-
lateral kidney. The hemodynamic changes noted in
the infused kidney were comparable to those seen in
human ARF. A major criticism of these studies,
however, is that the renal failure was not shown to be
reversible, as it typically is in man. In the present
study, we have reexamined the NE-induced model
of ARF in the dog with the particular purpose of
finding a set condition which would cause ARF and
yet allow recovery of renal function within a period
of time comparable to that usually seen in the human
disease.
Methods
Protocol 1: Two-hour vs. 40-mm infusion of nor-
epinephrine into one renal artery of intact dogs. In
this set of preliminary studies, two groups (each
consisting of four dogs) were studied. The studies
were performed under pentobarbital anesthesia (20
to 30 mg/kg of body wt, i.v.). An angiographic cathe-
ter (7—8 French) was introduced into a femoral artery
and guided, under fluoroscopic control, into one re-
nal artery. Using small flushes of dilute contrast
medium, the catheter was positioned carefully to
avoid obstruction of renal blood flow. Once the cath-
eter was in place, NE was infused into the renal
artery at a rate of 0.75 sgIkg/min. In the first group of
four dogs, the NE infusion was given for 2 hr. In the
second group, the infusion was given for only 40 mm.
The dogs were then allowed to recover from anes-
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thesia and were again given their standard diet. Eight
weeks later, the animals were again anesthetized and
prepared for acute clearance studies. Through bilat-
eral flank incisions, the renal veins and ureters were
cannulated. Clearances of inulin as an index of gb-
merubar filtration rate (GFR) and para-aminohippur-
ate (PAH) were measured by standard techniques.
Renal blood flow (RBF) was calculated from the
PAH clearance with correction for extraction. In
kidneys with no urine formation, RBF was measured
with an electromagnetic flow probe. Creatinine was
measured with an autoanalyzer (Technicon). Plasma
renin activity was measured by radioimmunoassay
[3]. Plasma and urine osmolality measurements were
done with an osmometer (Advanced Instruments).
Protocol 2: Effect of 40-mm infusion of norepi-
nephrine into the renal arteries of previously unine-
phrectomized dogs. In this second set of studies, one
kidney was removed 2 to 3 weeks before the experi-
ments started, and then the remaining kidney re-
ceived a 40-mm infusion of NE (0.75 sg/kg/min)
through the renal artery. At the time of the NE
infusion and at frequent intervals thereafter, the ani-
mals were weighed. Blood and urine samples were
obtained at the same intervals. These samples were
obtained while the dogs were conscious and after
they had fasted overnight. Creatinine and osmolality
were measured in both plasma and urine. Plasma
renin activity (PRA) was also measured at the same
time.
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Statistical analysis was performed by analysis of
variance using Dunnett's method for multiple com-
parisons with the control [4]. Student's t test was
used for single comparisons. A P value of < 0.05
was considered statistically significant. All data are
expressed as the mean SEM.
Results
Protocol I: Etj'cts t 2-hr vs. 40-mm infusion of
norepinephrine into one renal artery of intact dog.
The data from protocol 1 is presented in Table 1.
Renal weight, GFR, and RBF were all significantly
lower at the end of 8 weeks in the infused kidney of
dogs which had received a 2-hr intrarenal infusion of
NE than they were in those which had received only
a 40-mm infusion. There was no difference in the
mean weights of the contralateral kidneys from the
two groups. The relative renal sizes at 8 weeks for
the 2-hr vs. 40-minute infusion are shown in Figure 1.
Protocol 2: Effects of 40-mm infusion of norepi-
nephrine into the renal arteries of previously tinine-
Table 1. Protocol I: Kidney weight, GFR, and renal blood flow 8
weeks after a 2-hr or 40-mm intrarenal infusion of norepinephilne
(0.75 j.gIkgImin)a
n
2-hr
orepinephnne
infusion
40-mm
norepinephrine
infusion
Kidney wt, g
Infused 15.8 1.5 P <0.005 50.2 6.1
Contralateral 53.9 7.3 NS 52.2 3.5
GFR, mi/mm
Infused 1.3 1.3 P <0.01 24.3 5.9
Contralateral N.D. 40.2 4.9
Renal blood
flow, in//mm
Infused 10 0 P <0.05 209 67
Contralateral N.D. 274 55
N.D. = Not done
phrectoinized dogs. Two of the nine animals in this
group became anuric and died within 2 weeks. The
remaining seven dogs survived the 8-week period of
the study. In the seven surviving animals, oliguria
Fig. 1. Infused kidney 8 weeks following 40-mm (left) or 2-hr (right) intrarenal norepinephrine
infusion. A wedge section for histologic purposes was removed from the right kidney prior to
this photograph.
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was not a feature of the ARF. Three hours after the
NE infusion, urine flow had almost doubled from
0.51 0.19 to 0.99 0.28 mI/mm. For the next 8
weeks, urine flow remained at or above control val-
ues. The plasma creatinine concentration, however,
began to rise within 3 hours of the NE infusion and
reached its peak at 7 days. It then began to fall until it
was only slightly above the control value at 56 days
(Fig. 2). Clearance of inulin fell from a control value
of 55.5 5.7 mllmin to a low value of 10.7 2.9 ml!
mm (P <0.01) 24 hr after the infusion. Eight weeks
after the infusion, the inulin clearance had returned
to 27.3 5.4 mI/mm.
The depression in renal tubular function, as as-
sessed by the urine to plasma (U/P) ratio of creati-
nine, was maximal 3 hours after the NE infusion (206
51 toll 3, P <0.01) and returned to 95 25,8
weeks after the infusion (Fig. 2). Similarly, the U/P
osmolality fell from a control value of 4.4 0.4 to a
low value of 1.4 0.1 (P <0.01) 3 hr after the NE
infusion and returned to 2.9 0.6 8 weeks after the
infusion.
Three hours after the infusion, PRA was elevated
from 10.8 3.7 to 24.4 4.8 ng!ml!hr, P <0.01, but
at 24 hr and on subsequent days, PRA was not
different from controls. Since the renin values at 3
hours were obtained during anesthesia and the later
ones were not, the effect of anesthesia alone on PRA
was examined in a second group of animals. PRA
values obtained before and 3 hours after pentobarbi-
tal anesthesia in nine uninephrectomized, but other-
wise healthy dogs, revealed no significant changes
(2.5 0.8 to 1.6 0.3 ng/ml/hr, P = NS).
At no time during the postinfusion period did the
mean weights of the animals differ significantly from
control.
Discussion
Two recent studies describe the characteristics of
an ischemic model of ARF induced by the unilateral
infusion of NE into a renal artery of the dog [1, 2].
When animals were studied 48 hr after the infusion,
RBF had returned to 60% of control values, and
GFR was unmeasurably low [2]. These hemody-
namic abnormalities are similar to those noted in
patients with ARF [5]. ARF in man, however, typi-
cally undergoes spontaneous remission, and this fea-
ture was not evaluated in these initial investigations
with the NE-induced model in the dog.
In the present study, we found that the dose of NE
previously used (0.75 g/kg/min for 2 hr) caused
renal failure which was not spontaneously reversi-
ble. GFR did not return, and the kidney was found to
be severely shrunken at the end of 8 weeks (Fig. 1).
When the NE was infused for only 40 mm, however,
the ARF which followed was much more like that
seen in man. Its mortality rate was 22%, well within
the range of 10 to 50% commonly noted in man. The
severe impairment of GFR and the lesser reduction
in RBF during the early course of the disorder also
conformed to the familiar pattern seen in the human
disorder. Similarly, the impaired renal concentrating
ability in the early stages of our experiments was
comparable to what occurs during a similar period of
time in human ARF. Most important, however, GFR
and renal concentrating ability returned toward nor-
mal within the course of the study.
It is also noteworthy that high PRA was observed
early in the course of the renal failure in our study, as
it has in man [7]. The return of PRA to control values
after 24 hr of ARF in our study, however, suggests
that elevated PRA are not necessary in the mainte-
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Fig. 2. Effect of4O-min norepinep/irine infusion on plasma creati-
nine (top) and urine to plasma ratio (U/P) of creatinine (bottom).
Arrow indicates timing of norepinephrine (NE) infusion. Data are
plotted as mean SEM.
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nance of ARF in this model. This observation is
consistent with that of Baehler, Kotchen, and Ott
[81.
Summary. The present study has defined condi-
tions whereby a reversible form of ischemia-induced
ARF can be produced in the dog. Unlike previous
studies [9—Il] which examined the acute phase of
NE-induced ARF, this study demonstrates the feasi-
bility of using the model for the longitudinal study of
ARF. Such a model may be useful in studying the
pathologic and physiologic changes which occur dur-
ing different phases of ARF. Perhaps most impor-
tant, this model should also provide a setting in
which treatment measures, either prophylactic or
therapeutic for ARF, can be examined.
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